NEW YORK, May 5, 2020 /PRNewswire/ -- Halper Sadeh
LLP, a global investor rights law firm, is investigating whether
the sale of Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) to Alexion
Pharmaceuticals, Inc. for $18 per
share in cash is fair to Portola shareholders. On behalf of Portola
shareholders, Halper Sadeh LLP may seek increased consideration for
shareholders, additional disclosures and information concerning the
proposed transaction, or other relief and benefits.
If you are a Portola shareholder and would like to discuss your
legal rights and options, please visit Portola Merger or
contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or
sadeh@halpersadeh.com or zhalper@halpersadeh.com.
The investigation concerns whether Portola and its board of
directors violated the federal securities laws and/or breached
their fiduciary duties to shareholders by failing to: (1) obtain
the best possible consideration for Portola shareholders; (2)
determine whether Alexion is underpaying for Portola; and (3)
disclose all material information necessary for Portola
shareholders to adequately assess and value the proposed
transaction.
If you are a Portola shareholder and would like to discuss your
legal rights and options, please visit
https://halpersadeh.com/actions/portola-pharmaceuticals-inc-merger-alexion
or contact Daniel Sadeh or
Zachary Halper at (212) 763-0060 or
sadeh@halpersadeh.com or zhalper@halpersadeh.com.
Halper Sadeh LLP represents investors all over the world
who have fallen victim to securities fraud and corporate
misconduct. Our attorneys have been instrumental in implementing
corporate reforms and recovering millions of dollars on behalf of
defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar
outcome.
Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/portola-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-sale-of-portola-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-301053144.html
SOURCE Halper Sadeh LLP